Webinar: Hepatitis B Overview and Innovations in Immunization

Dynavax is hosting a webinar on Hepatitis B presented by: John Youhanna, PharmD, RPh, Regional Medical Director, Dynavax Technologies.

Now more than ever, it is important to prioritize the protection of healthcare workers who are at risk from infectious diseases, particularly hepatitis B, a potentially deadly virus that is spread through contact with infected blood and bodily fluids and can live on surfaces for at least seven days.1,2,3

Please join us to discuss why Hepatitis B is a current threat to our healthcare community and learn more about innovations in protection through vaccination.

This educational presentation will include a live Q & A session.

Click below to register!

June 18th

1pm – 2pm EST

June 23rd

2pm – 3pm EST

June 25th

12pm – 1pm EST

1 Centers for Disease Control and Prevention. Hepatitis B. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015:149-174. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepb.pdf. Accessed October16, 2017.

2. Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol.2015;7(24):2503-2509. doi:10.4254/wjh.v7.i24.2503

3. Than TT, Jo E, Todt D, et al. High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides. J Infect Dis. 2018 Oct 24. doi: 10.1093/infdis/jiy620. [Epub ahead of print].